Extended Data Fig. 3: Transient reduction of germinal centre (GC) B cells around the time of peak T cell response.
From: Mechanism of EBV inducing anti-tumour immunity and its therapeutic use

a, Frequency of spontaneous GC B cells (CD19+FAShighCD38low) analysed by FACS in the mesenteric lymph nodes of the inducible LMP1-expressing ERT2-CL mice and littermate controls (ERT2-C) after tamoxifen treatment. Data are mean ± s.e.m. b, c, Numbers (b) and representative FACS plots (c) of GC B cells from the indicated mice 7 days post-tamoxifen treatment as in a. Statistics and reproducibility are presented in the Supplementary Information.